⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12699753 | 1.00 | — | — | |
| SCHEMBL1161879 | 1.00 | — | — | |
| Methane SCHEMBL10516513 | 0.98 | CHRNB2 (0.52) | — | |
| Hydrochloric Acid SCHEMBL17364117 | 0.98 | CHRNB2 (0.52) | — | |
| Hydrochloric Acid SCHEMBL3911969 | 0.98 | CHRNB2 (0.52) | — | |
| Hydrochloric Acid SCHEMBL594534 | 0.98 | CHRNB2 (0.52) | — | |
| Acetic Acid Methyl Ester SCHEMBL9148923 | 0.94 | CHRNB2 (0.48) | — | |
| SCHEMBL4673135 | 0.88 | SLC6A1 (0.59) | — | |
| SCHEMBL13598498 | 0.88 | SLC6A1 (0.59) | — | |
| SCHEMBL763374 | 0.88 | SLC6A1 (0.59) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 674 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119968375-A | Heterocyclic derivatives as Janus kinase inhibitors | 奇斯药制品公司 | 2025-05-09 | — | — | CN | claimed |
| CN-114650993-A | PD-1/PD-L1 inhibitor and preparation method and application thereof | 上海华汇拓医药科技有限公司 | 2022-06-21 | — | — | CN | claimed |
| CN-104703987-B | PDE9 inhibitors having an imidazopyrazinone backbone | H.隆德贝克有限公司 | 2017-05-03 | — | — | CN | claimed |
| CN-104761557-B | Hexahydro-1H-pyrrolo[3,4-d]pyrimidine compound and preparation method thereof | 河南师范大学 | 2017-02-22 | — | — | CN | claimed |
| CN-104402791-B | Preparation method for nebracetam | 河南师范大学 | 2017-02-01 | — | — | CN | claimed |
| US-12637440-B2 | Amide derivative useful as diacylglycerol acyltransferase 2 inhibitor, and use thereof | LG CHEM, LTD. (KR) | 2026-05-26 | — | — | US | disclosed |
| EP-4712961-A2 | KRAS G12S AND G12C INHIBITORS | Mirati Therapeutics, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| EP-4387963-B1 | PHENYL- AND PYRIDOPYRAZOLE DERIVATIVES AS INHIBITORS OF DDR1 | REDX PHARMA LTD (GB) | 2025-12-24 | — | — | EP | disclosed |
| EP-4655402-A1 | NUCLEIC ACID VACCINES FOR VARICELLA-ZOSTER VIRUS (VZV) | Providence Therapeutics Holdings Inc. (CA) | 2025-12-03 | — | — | EP | disclosed |
| EP-4642450-A2 | EP2 ANTAGONIST COMPOUNDS | Reservoir Neuroscience, Inc. (US) | 2025-11-05 | — | — | EP | disclosed |
| EP-4608831-A1 | COMPOUNDS AND USES THEREOF | Suzhou Zanrong Pharma Limited (CN) | 2025-09-03 | — | — | EP | disclosed |
| US-20250197387-A1 | BCL-XL DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2025-06-19 | — | — | US | disclosed |
| CN-1024791-C | Process for preparing pyrrolidine derivatives and their salts | FUJISAWA PHARMACEUTICAL CO (JP) | 1994-06-01 | — | — | CN | disclosed |
| EP-0307140-B1 | Oxadiazolyl-azabicycloheptanes for the treatment of senile dementia | MERCK SHARP & DOHME (GB) | 1994-03-02 | — | — | EP | disclosed |
| CN-1082547-A | Azabicyclic compounds | FUJISAWA PHARMACEUTICAL CO (JP) | 1994-02-23 | — | — | CN | disclosed |
| CN-1020899-C | METHOD FOR PREPARATION OF PYRROLIDINE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO (JP) | 1993-05-26 | — | — | CN | disclosed |
| CN-1042355-A | The preparation method of pyrrolidin derivatives and salt thereof | FUJISAWA PHARMACEUTICAL CO (JP) | 1990-05-23 | — | — | CN | disclosed |
| EP-0307142-A1 | Thiadiazoles useful in the treatment of senile dementia | MERCK SHARP & DOHME LTD. (GB) | 1989-03-15 | — | — | EP | disclosed |
| EP-0307140-A1 | Oxadiazolyl-azabicycloheptanes for the treatment of senile dementia | MERCK SHARP & DOHME LTD. (GB) | 1989-03-15 | — | — | EP | disclosed |
| CN-88102511-A | PYRROLIDINE DERIVATIVES | — | 1988-11-23 | — | — | CN | disclosed |